The Glocalisation Challenge

December, 2022    SMM-258 The Glocalisation Challenge The concept of glocalisation contrasts the increasingly global nature of the pharma market with the continuing importance of locally-specific market conditions. The implication is that firms need to develop...

Roche’s Creative Destruction

December, 2022    SMM-259 Roche’s Creative Destruction A recent statement from Roche illustrates how Darwinian mechanisms act in our evolving market. Looking at the turmoil currently faced by start-up and early stage biotechs, we also see how difficulties can...

Cross-functional alignment

October, 2022    SMM-255 Cross-functional alignment This is the third in my series of articles about the human side of strategy execution, published in Pharmaceutical Marketing Europe. This time I look at how cross-functional alignment works...

COVID-19’s consequences

October, 2022    SMM-256 COVID-19’s consequences I love the fact that our industry is evolving in surprising and hard-to-predict ways. Here’s why, in this complex adaptive ecosystem, COVID-19 vaccines might rhyme with antibiotics.